Clinical Trial

The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research

Recruiting
View on ClinicalTrials.gov →
Summary
Acquire residual human specimens and/or samples from patient samples which were sent for testing at LabPMM, LLC for Clinical Research
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2024-01-15; most recent amendment 2025-05-02.
Status change: Not Yet Recruiting → Recruiting 2025-05-02
Trial Details
NCT Number NCT06222164
Lead Sponsor Invivoscribe, Inc.
Conditions Hematologic Diseases
Enrollment 2,000 participants
Start Date 2024-03-30
Primary Completion 2027-03-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2025-05-04